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Abstract  
Background. There is limited data available on potential biological effects of E-cigarettes on human oral tissues. The aim 
of this study was to evaluate the effects of E-cigarette liquid on the proliferation of normal and cancerous monolayer and 3D 
models of human oral mucosa and oral wound healing after short-term and medium-term exposure.  
Methods. Normal human oral fibroblasts (NOF), immortalized OKF6-TERET-2 human oral keratinocytes, and cancerous 
TR146 keratinocyte monolayer cultures and 3D tissue engineered oral mucosal models were exposed to different concentra-
tions (0.1%, 1%, 5% and 10%) of E-cigarette liquid (12 mg/ml nicotine) for 1 hour daily for three days and for 7 days. Tissue 
viability was monitored using the PrestoBlue assay. Wounds were also produced in the middle surface of the monolayer 
systems vertically using a disposable cell scraper. The alterations in the cell morphology and wound healing were visualized 
using light microscopy and histological examination. 
Results. Statistical analysis showed medium-term exposure of TR146 keratinocytes to 5% and 10% E-liquid concentrations 
significantly increased the viability of the cancer cells compared to the negative control. Short-term exposure of NOFs to 
10% E-liquid significantly reduced the cell viability, whereas medium-term exposure to all E-liquid concentrations signifi-
cantly reduced the NOF FHOOV¶ viability. OKF6 cells exhibited significantly lower viability following short-term and medium-
term exposure to all E-cigarette concentrations compared to the negative control. 3D oral mucosal model containing normal 
oral fibroblasts and keratinocytes showed significant reduction in tissue viability after exposure to 10% E-liquid, whereas 
medium-term exposure resulted in significantly lower viability in 5% and 10% concentration groups compared to the negative 
control. There was a statistically significant difference in wound healing times of both NOF and OKF6 cells after exposure 
to 1%, 5% and 10% E-cigarette liquid. 
Conclusion. Medium-term exposure to high concentrations of the E-cigarette liquid had cytotoxic effects on normal human 
oral fibroblasts and OKF6 keratinocytes, but a stimulatory cumulative effect on the growth of cancerous TR146 keratinocyte 
cells as assessed by the PrestoBlue assay and histological evaluation of 3D oral mucosal models. In addition, E-liquid expo-
sure prolonged the wound healing of NOF and OKF6 oral mucosa cells. 
Key words: Electronic cigarette, cytotoxicity, keratinocyte, fibroblast, tissue engineering, wound healing. 
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Introduction 
lectronic cigarette (EC) use has rapidly increased 
since they were introduced. There are significant 
debates in healthcare and regulatory bodies on this 
subject, and conflicting advice has been given regard-
ing the appropriate use of ECs. 
Data from an international survey showed 15% use 
in the US, 10% use in the UK, 4% use in Canada, and 
2% use in Australia and the number of young people 
trying the ECs is significantly increasing.1 The rate of 
EC use by middle and high school students in the US 
has tripled from 2011 to 2013. A three-fold increase 
in EC use was reported from 2010 to 2012 in the Great 
Britain.2 
There is a growing body of evidence that demon-
strates ECs are an effective aid to smoking cessation, 
and they have significant potential to reduce tobacco 
smoke-related oral diseases.3-5 However, it is im-
portant to balance the potential adverse effects of ECs 
aerosol with the benefits of reducing tobacco smok-
ing.  
Several chemical studies have analyzed the compo-
sition of liquids and aerosols from ECs.6-12 Several po-
tentially harmful materials have been identified in 
ECs, including diethylene glycol, propylene glycol, 
nitrosamines, toluene, acrolein, acetaldehyde, formal-
dehyde, nickel, lead, aluminum, chromium, cadmium, 
and silicon. Some ingredients, such as Diacetyl, used 
in flavored e-liquids are safe to consume orally, 
though perhaps not to inhale, as it has been associated 
with bronchiolitis obliterans. 
Although a few animal studies have failed to show 
any obvious adverse systemic toxicity associated with 
inhaled glycerol or propylene glycol, 13-14 concerns 
have been raised for humans in terms of respiratory 
tract irritation,15 and evidence for potential localized 
adverse effects of inhaled glycerin is sparse. An ani-
mal study has shown evidence of mild epithelial squa-
mous metaplasia following long-term inhalation of 
aerosolized glycerol in rats.16 
It has been demonstrated that exposure to ECs im-
pairs pulmonary antibacterial and antiviral defenses in 
a mouse model.17 In vitro toxicity profiles of elec-
tronic and tobacco cigarettes, smokeless tobacco, and 
nicotine replacement therapy products have been 
compared in a study using Ames Salmonella muta-
genicity testing.18 
The nicotine in the ECs is mainly absorbed through 
the buccal mucosa and pharyngeal mucosa. Although 
nicotine has been shown to have wound healing and 
angiogenic properties,19 which can make it a potential 
therapeutic agent, there are some concerns regarding 
its ability to promote lung tumor growth through dif-
ferent possible mechanisms, including angiogenesis, 
cell proliferation, and cell migration.20-21 
There are few representative studies that illustrate 
the negative effects of ECs on the human oral mucosa. 
Evidence supports that conventional smoking has a 
QHJDWLYHLQIOXHQFHRQDSDWLHQW¶VUHVSRQVHDVZHOODV
their treatment outcome, following non-surgical, sur-
gical, and regenerative periodontal treatment. Smok-
ing also impairs all wound healing phases (particu-
larly the inflammatory and proliferation phases, 
which lead to delays in wound healing).22-26 
Clinical studies of ECs have reported mild harmful 
effects of vaping on selected cardiovascular27-28 and 
respiratory functional outcomes29-31 to a considerably 
less extent when compared with conventional ciga-
rette smoking32. However, it is difficult to assess the 
prognostic implications of these studies, and there is 
a need for further research in this area. 
Clinical research and survey-type studies to date 
have shown that the most common patient-reported 
side effects were symptoms such as xerostomia, throat 
irritation, and cough.33-36 
A five-year multicenter cohort study was conducted 
to assess the long-term efficacy and safety of ECs,37 
and a pilot study investigated the oral mucosa perfu-
sion of intraoral free flaps in EC users and smokers.38 
Several toxicological studies have been conducted 
on ECs, using monolayer cell culture systems.39-43 
However, there is no study published in the literature 
comparing the effects of E-cigarette liquid on differ-
ent normal and cancerous oral mucosa cells, including 
3D tissue-engineered models of the human oral mu-
cosa. Therefore, this study aimed to evaluate the bio-
logical effects of E-cigarette liquid on both full-thick-
ness 3D oral mucosa models and monolayer cell cul-
ture systems utilizing normal oral fibroblasts, OKF6-
TERET2 oral keratinocytes, and cancerous TR146 
keratinocytes, following short-term (three days) and 
medium-term (seven days) exposure to flavorless 
electronic cigarette liquid. Additionally, this study 
aimed to investigate the influence of E-cigarette liquid 
on oral mucosa wound healing, using normal oral fi-
broblasts and OKF6 oral keratinocyte cell cultures. 
Methods  
Cell Source and Biological Systems 
Normal human oral fibroblast cells were obtained 
from the stocks stored in liquid nitrogen in the labor-
atories of the School of Clinical Dentistry at the Uni-
versity of Sheffield. These cells had been previously 
obtained from healthy patients undergoing oral 
E 
56   Shaikh et al. 
 
surgery at Charles Clifford Dental Hospital with their 
written informed consent under appropriate ethical 
approval from the UK National Research Ethics Ser-
vices Committee. 
The immortalized OKF6/TERT-2 human oral 
keratinocyte cell line was kindly provided by Brigham 
and Women's Hospital, Harvard Institute of Medicine, 
USA.  
The cancerous human TR146 cell line was derived 
from a neck lymph node metastasis originating from 
a carcinoma of the oral buccal mucosa. These cells 
were kindly provided by Cancer Research UK. 
Five different biological systems were tested in 
this study, including: 
x Monolayer cultures of normal oral fibroblasts 
(NOF) 
x Monolayer cultures of the immortalized oral 
keratinocyte cell line (OKF6/TERT-2) 
x Monolayer cultures of cancerous TR146 keratino-
cytes 
x Co-cultures of NOF and OKF6/TERT-2 cells 
x 3D tissue-engineered oral mucosa models using 
TR146 keratinocytes and NOFs 
Cell Culture 
Oral fibroblasts and keratinocytes were cultured in 
high-JOXFRVH 'XOEHFFR¶V PRGLILHG (DJOH¶V PHGLXP
(DMEM) (Sigma, UK), supplemented with 2% L-glu-
tamine (Sigma, UK), 100 IU:100 mg ml-1 Penicil-
lin/Streptomycin (Sigma, UK), and 10% fetal calf se-
rum (FCS) (Biowest Ltd., UK). 
Six-well plates were utilized for the monolayer cell 
cultures, inoculating 10,000 cells per well for NOFs, 
OKF6/TERT2 cells, and TR146 keratinocytes. Addi-
tionally, normal oral fibroblasts and keratinocytes 
were cultured together using six-well plates. 
The cultures were maintained in incubators at 5% 
CO2 at 37qC. The cells were cultured until 80௅100% 
confluency was achieved. 
Tissue-engineered 3D Oral Mucosa Models 
Full-thickness 3D tissue-engineered oral mucosa 
models were manufactured by air/liquid interface cul-
ture of TR146 keratinocytes seeded onto fibroblast-
populated collagen gels. 
A solution of 10 × DMEM, 8.5% (v/v) FBS, 2 mM L-
glutamine, reconstitution buffer (22 mg mLí1 sodium 
bicarbonate and 20 mM 4-(2-hydroxyethyl)-1-pipera-
zineethanesulfonic acid), and 5 mg mL-1 rat tail type I 
collagen (R & D system, UK) was prepared and neu-
tralized by 1-M sodium hydroxide to pH=7.4 in an 
ice-cold environment by keeping everything on ice. 
Normal oral fibroblasts were added to the solution at 
a concentration of 500,000 cells/model, and 1 mL of 
the resultant cell-containing collagen mixture was 
transferred to cell culture transwell inserts (0.4 µm 
pore size, Millipore), incubated at 37°C for 2 hours 
until solidified, and then completely submerged in 
complete DMEM for 3 days. Subsequently, 1×106 
keratinocytes were seeded onto each model and kept 
in submerged culture for three days, after which the 
oral mucosal models were raised to air/liquid interface 
and cultured for a further 7 days. 
Exposure Protocol 
Neutral E-Cigarette Liquid (Vype-UK) with no added 
flavors, containing medium nicotine level of 12 
mg/mL, was used in this experiment. Four different 
concentrations (0.1%, 1%, 5%, and 10%) of E-ciga-
rette liquid were prepared by diluting the E-liquid 
with DMEM. 
The monolayer cell culture systems and the 3D oral 
PXFRVDPRGHO¶VHSLWKHOLDOVXUIDFHVZHUHH[SRVHG WR
four different concentrations of E-cigarette liquid 
(0.1%, 1%, 5%, and 10%), to the negative control 
(DMEM) and the positive control (70% ethanol). The 
groups consisted of six samples each (n=6). 
All the samples were exposed to their respective re-
agents for one hour daily for three continuous days 
and incubated at 5% CO2 and 37ºC. Following the 
testing for the short-term exposure, the samples were 
washed twice with phosphate-buffered saline (PBS) 
(Sigma, UK), and the medium-term exposure contin-
ued for four more days by exposing the samples to the 
reagents for one hour daily, totaling seven days.  
Cell Viability Assay 
Following the short-term and medium-term exposures, 
tissue viability test was carried out using the Presto-
Blue assay. The PrestoBlue reagent (Biosource, Cam-
arillo, CA) was added to the samples at a ratio of 9:1 
(volume of cells and culture medium: volume of Pres-
toBlue reagent). The plates were then incubated for 60 
minutes at 37°C and 5% CO2. Following incubation, 
triplicate 200-PL samples were placed into the wells 
of a 96-well plate, and the fluorescence intensity of 
each well was measured at an excitation wavelength 
of 530 nm and an emission wavelength of 590 nm us-
ing a fluorescent plate reader (Infinite 200 PRO 
TECAN, Switzerland).  
Histological and Morphological Assessment 
The oral mucosa model samples were first fixed in 10% 
formalin solution for 24 hours; the samples were then 
mounted in Optimal Cutting Temperature (OCT) em-
bedding compound, followed by freezing at -20 to -
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80°C. Afterward, the samples were sectioned at a 
thickness of 10௅ȝPXVLQJa cryostat machine. The 
sections were then mounted on the histological 
slides. This was followed by drying the slides for 
around 30 minutes at room temperature. The slides 
were then stored in the freezer at -80°C until the pro-
cessing for hematoxylin and eosin (H&E) staining.  
The slides were examined under a light microscope 
by more than one histopathology expert to assess the 
changes in the connective tissue and the epithelial lay-
ers of the model following the exposure to test agents. 
Assessment criteria included the continuity and thick-
ness of the epithelium, cell morphology, presence or 
absence of pyknotic nuclei, presence of a distinct in-
terface between the epithelium and the connective tis-
sue layer. 
Wound Healing Assay  
Monolayer cultures of normal oral fibroblasts and 
OKF6/TERT-2 keratinocytes were developed in 6-
well tissue culture plates and divided into negative 
control (DMEM), positive control (70% ethanol), and 
test groups with various E-Cigarette concentrations 
(0.1%, 1%, 5%, and 10%) (n=6). The wounds were 
produced vertically in the middle of the surface of the 
monolayer systems using a disposable cell scraper. 
The test groups were exposed to the culture media 
containing E-cigarette liquid immediately before and 
continued daily after creating a wound, and then the 
wounds were monitored until complete healing had 
occurred. Microscopic images were obtained pre- and 
post-wound creation daily to assess the healing time 
in all the groups. 
Statistical Analysis 
SPSS 20 was used for statistical analysis. The normal-
ity of the data was analyzed using the normality test 
(Shapiro-Wilk test). Means of the samples were com-
pared with ANOVA, followed by multiple compari-
sons using post hoc Tukey tests to determine the dif-
ferences between the different groups. The level of 
significance for all the statistical tests was set at 
D=0.05. 
Results 
The results of the PrestoBlue assay for normal oral fi-
broblasts and OKF6/TERT-2 keratinocyte monolayer 
cell cultures exposed to different concentrations of the 
E-Liquid for three days and seven days are shown in 
Figure 1. Short-term exposure to 10% E-liquid solu-
tion caused a statistically significant reduction in the 
viability of NOFs (P<0.0001) compared to the nega-
tive control group. Following medium-term exposure, 
all the E-liquid concentration groups exhibited signif-
icantly lower viability compared to the negative con-
trol group. 
OKF6/TERT-2 keratinocyte monolayers showed 
significantly lower viability after short-term exposure 
to all the E-liquid concentrations, whereas medium-
term exposure resulted in significantly lower viability 
in all the groups except for 1% concentration group 
compared to the negative control group. 
The TR146 keratinocyte monolayers did not exhibit 
any statistically significant difference in the viability 
between different E-liquid concentration groups com-
pared to the negative control group after short-term 
exposure. However, medium-term exposure to 5% 
and 10% E-liquid solution caused a statistically sig-
nificant increase in the viability of TR146 keratino-
cytes compared to the negative control group (Figure 
2). 
Normal oral fibroblast and OKF6/TERT-2 keratino-
cyte co-culture system showed a significant reduction 
in cell viability in 10% E-liquid concentration group 
following short-term exposure. In contrast, medium-
 
Figure 1. Tissue viability of normal oral fibroblasts and 
OKF6 keratinocyte monolayer cell cultures exposed to 
different concentrations of E-liquid as assessed by the 
PrestoBlue assay. 
 
 
Figure 2. Tissue viability of TR146 keratinocyte mono-
layer cell cultures exposed to different concentrations 
of E-liquid as assessed by the PrestoBlue assay. 
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term exposure resulted in significantly lower viability 
in 5% and 10% concentration groups (P<0.0001) 
compared to the negative control group (Figure 3). 
Histologically, the 3D oral mucosal models utilizing 
the NOFs and TR146 keratinocytes showed an in-
crease in the thickness of the cancerous epithelial 
layer in high E-liquid concentration groups compared 
to the negative control after short-term and medium-
term exposure (Figures 4 and 5). 
Figure 6 demonstrates microscopic views of the 
wound healing at different stages for normal oral fi-
broblasts and OKF6/TERT-2 keratinocytes. Table 1 
presents the mean values and standard deviations of 
the total time of wound healing for the control and test 
groups. There was a statistically significant difference 
in the wound healing time of both NOF and 
OKF6/TERT-2 monolayer systems exposed to 1%, 
5%, and 10% E-liquid solutions compared to those of 
the negative control group (P<0.05).  
Discussion 
Three different cell types, including NOFs, 
OKF6/TERT2 keratinocytes, and cancerous TR146 
keratinocytes, were used in this study. Normal oral fi-
broblasts were selected as they are thought to play a 
major role in mucosal wound healing; they are also 
responsible for extracellular matrix synthesis in the 
connective tissue layer. OKF6/TERT-2 keratinocytes 
exhibit high reproducibility, avoid batch-to-batch var-
iations; they were selected to represent normal oral 
epithelial cells. Conversely, squamous cell carci-
noma-derived TR146 cells were utilized to assess the 
effects of E-liquid on oral cancer cells. 
E-liquid with no added flavors was used to elimi-
nate the confounding effects of different additives that 
are observed with various types of flavoring agents 
used in E-cigarettes. Different studies have shown 
that certain flavors, such as menthol, cinnamon, cara-
mel, butterscotch, bubble-gum, and coffee, have more 
cytotoxic effects on cells compared to some other fla-
vors.39-41 
Four different concentrations (0.1%, 1%, 5%, and 
10%) of E-liquid solution were prepared to assess the 
effects of various concentrations of E-liquid on the 
cells, covering the range from light vapers to heavy e-
cigarette users. The duration of exposure included 
three days and seven days to simulate short-term and 
medium-term vaping. 
In this study, electronic cigarette liquid exhibited an 
adverse effect on the viability of normal oral 
 
Figure 4. Histological sections of 3D tissue-engineered oral mucosa models after short-term exposure to (A) 0.1% E-
liquid; (B) 1% E-liquid; (C) 5% E-liquid; (D) 10% E-liquid; (E) negative control; (F) positive control (H & E staining, 
original magnification ×10). 
 
Figure 3. Tissue viability of normal oral fibroblast and 
OKF6 keratinocyte 3D co-culture systems exposed to 
different concentrations of E-liquid as assessed by the 
PrestoBlue assay. 
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fibroblasts and OKF6/TERT-2 keratinocytes. These 
results are consistent with a previous study that tested 
different types of E-cigarette liquids on the human 
periodontal ligament fibroblasts and showed a reduc-
tion in the viability of cells in the samples that were 
exposed to E-liquids.39 
Conversely, a dose-dependent stimulatory effect of 
E-liquid on the growth of cancerous TR146 cells was 
observed in our study, exhibiting increased viability 
and proliferation of TR146 cells with increasing con-
centrations of E-liquid. Similarly, histological evalu-
ation of the 3D oral mucosa models showed an in-
crease in the thickness of the cancerous epithelial 
layer exposed to high concentrations of E-liquid. This 
is the first study reporting the use of a full-thickness 
3D tissue-engineered oral mucosal model for the bio-
logical evaluation of electronic cigarettes on cancer-
ous oral tissues. These findings have not been re-
ported previously and might indicate tumor-promot-
ing effects of the ingredients of the E-liquid tested in 
this study.  
Previous studies have raised some concerns regard-
ing the potential effects of nicotine on promoting tu-
mors in the lungs through various possible mecha-
nisms, such as cell migration, proliferation and angi-
ogenesis.20-21  
The influence of nicotine on dysplastic oral 
keratinocyte cell line and precancerous lesions of the 
mouse tongue has been investigated previously, 
showing an inhibitory effect on apoptosis and a 
 
Figure 5. Histological sections of 3D tissue-engineered oral mucosa models after medium-term exposure to (A) 0.1% 
E-liquid; (B) 1% E-liquid; (C) 5% E-liquid; (D) 10% E-liquid; (E) negative control; (F) positive control (H & E 
Staining, original magnification ×10). 
 
Figure 6. Microscopic views of the wound healing assay showing (A) the center of the wound on day 1 of fibroblast 
culture; (B) central wound on day 3 of fibroblast culture; (C) completely healed fibroblast cultures; (D) the center of 
the wound on day 1 of keratinocyte culture; (E) central wound on day 3 of keratinocyte culture; and (F) completely 
healed keratinocyte cultures. 
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stimulatory effect on the growth of oral precancerous 
lesions.44 Similarly, Chernyavsky et al42 assessed the 
tumor-promoting effects of nicotine on oral and lung 
cancer cells. Nicotine exhibited resistance to apopto-
sis, increasing the counts of both lung and oral cancer 
cells. 
Some other studies have used monolayer cell cul-
ture systems to assess the cytotoxicity of electronic 
cigarettes.39-43 Different types of cell lines have been 
exposed to either electronic cigarette aerosols or E-
liquid solutions. These studies have also confirmed 
the adverse effects of E-cigarettes, with some cell 
lines being more sensitive than the others. 
Recently, studies have been conducted to assess the 
effects of electronic cigarettes on oral mucosal cells. 
In a study by Yu et al,43 electronic cigarette exposure 
reduced cell viability along with high levels of apop-
tosis and necrosis, with alterations in augmented 
DNA strands, in normal epithelial and squamous cell 
carcinoma (head and neck) cell lines. However, Gut-
tenplan et al44 observed a stimulatory effect of E-cig-
arette exposure on the proliferation of human oral leu-
koplakia cells. Conversely, Willershausen et al37 re-
ported a reduction in cell proliferation of periodontal 
ligament fibroblasts after exposure to various E-liq-
uids. 
Sundar et al45 utilized human periodontal ligament 
fibroblasts and a 3D gingival epithelium-only tissue 
model to assess the effects of electronic cigarettes, re-
porting an increase in pro-inflammatory cytokines 
and an elevated oxidative/carbonyl stress resulting in 
the production of high levels of cyclooxygenase-2 and 
prostaglandin E2. Although the 3D split-thickness tis-
sue model used in this study was more clinically rele-
vant than monolayer cell culture systems, it lacked the 
connective tissue component.  
A study by Sancilio et al46 raised concerns regarding 
E-cigarette¶V role in the pathogenesis of oral diseases. 
Human gingival fibroblasts exposed to E-Liquids 
showed decreased production of collagen I and in-
creased levels of lactate dehydrogenase. 
There is a lack of research on the effects of E-ciga-
rettes on human oral mucosa wound healing. It has 
been indicated that exposure to E-cigarettes reduces 
the viability of cells and compromises cell migra-
tion.46 Therefore, this study aimed to investigate the 
effects of E-cigarette liquids with different concentra-
tions on oral mucosa wound healing. Two wound 
healing models were used in this study based on nor-
mal oral fibroblasts to represent connective tissue 
wound healing and OKF6/TERT2 keratinocytes to 
simulate epithelial wound healing. The results of this 
in vitro assay were consistent with the results of the 
cytotoxicity tests and indicated that the E-liquid tested 
in this study might have potential dose-dependent ad-
verse effects on oral mucosa wound healing, prolong-
ing the healing times both in the epithelial and the 
connective tissue layers. In a recent study,50 human 
gingival fibroblasts were exposed to three different 
groups (cigarette smoke condensate, nicotine-free or 
nicotine-rich electronic cigarette vapor condensates), 
and the results showed that both cigarette smoke and 
electronic cigarette vapors affected the proliferation 
and migration of fibroblasts. Additionally, the cell 
scratch test revealed delayed wound healing, con-
sistent with the findings of this study. 
There were certain limitations in our study; firstly, 
this was an in-vitro study, and the results may not be 
extrapolated to an in-vivo situation. Secondly, only E-
liquids were tested in this study rather than the E-cig-
arette aerosols. Ideally, the cytotoxic effects of E-cig-
arettes should be assessed in both liquid and vapor 
form, as the E-cigarette vapors come into direct con-
tact with oral mucosa. 
Hence, further research is required to overcome 
these limitations by assessing E-cigarettes of different 
flavors and various concentrations of nicotine. The 
liquid, as well as the vapor form of E-cigarettes, can 
be tested and compared with the conventional ciga-
rette smoke. Furthermore, evaluating the long-term 
effects of E-cigarettes would further add to our under-
standing of the biological effects of E-cigarettes on 
human oral tissues. 
Conclusion 
This in vitro study revealed that short-term and me-
dium-term exposure to the electronic cigarette liquid 
had dose-dependent cytotoxic effects on normal hu-
man oral fibroblasts and OKF6/TERT-2 oral keratino-
cytes. However, E-liquid exposure had a cumulative 
stimulatory effect on the growth of cancerous TR146 
keratinocytes using both monolayer and 3D cell cul-
ture systems. 
The full-thickness 3D tissue-engineered human oral 
Table 1. Mean values and standard deviations of the to-
tal time of wound healing for the control and test 
groups 
Cells Groups Mean (days) SD 
NOF 0.1% E-liquid 6.17 0.75 
1% E-liquid 7.33 0.51 
5% E-liquid 9.167 0.75 
10% E-liquid 12.33 1.03 
Control (DMEM) 5.17 0.41 
OKF6/ 
TERT2 
0.1% E-liquid 6.00 0.63 
1% E-liquid 6.67 0.52 
5% E-liquid 7.67 0.52 
10% E-liquid 10.50 0.84 
Control (DMEM) 5.05 0.63 
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mucosal model has the potential to be used as a clini-
cally relevant biological test system for the evaluation 
of electronic cigarettes.  
In addition, E-liquid exposure prolonged the wound 
healing of both normal oral fibroblasts and 
OKF6/TERT-2 epithelial cells. 
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